Viva Biotech Holdings's total assets for Q4 2025 were ¥7.20B, an increase of 4.64% from the previous quarter. HK:1873 total liabilities were ¥3.19B for the fiscal quarter, a 7.35% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.